Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Substituted chromeno[2,3-d]pyrimidines as NF-κB inhibitors

Substituted chromeno[2,3-d]pyrimidines as NF-κB inhibitors

US Patent 11266648 · Granted Mar 8, 2022

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Substituted diazaspiroalkanes as androgen receptor modulators2023
Methods of treating cancer with small molecule NF-κB inhibitors2021
Methods of treating cancer with small molecule NF-κB inhibitors2021
Thioacetate compounds, compositions and methods of use2021
Substituted diazaspiroalkanes as androgen receptor modulators2020
Small molecule NF-κB inhibitors2020
Small molecule NF-κB inhibitors2020
Thioacetate compounds, compositions and methods of use2019
Small molecule NF-κB inhibitors2019
Small molecule NF-κB inhibitors2019
Substituted diazaspiroalkanes as androgen receptor modulators2018
C-Rel inhibitors and uses thereof2018